Hydrocodone and Acetaminophen were used as active ingredients in the branded drug Lortab 7.5-325 mg (g036 pill). These two components are generic variants. Both these components work as pain relievers. Lortab medicine contained 7.5 mg of hydrocodone and 325 mg of acetaminophen. Lortab 7.5-325 mg tablet was available in tablet and capsule forms.

Both Hydrocodone and acetaminophen worked as a combined drug to reduce mild to severe pain in individuals. Hydrocodone (7.5 mg) has opioid analgesic characteristics, whereas acetaminophen (325 mg) is a non-opioid painkiller.

According to the Controlled Substance Act (CSA), Lortab g036 white oval pill belonged to a Scheduled II controlled substance which had a high potential for addiction or misuse. The dose was administered by a healthcare provider depending on the person’s medical condition.

The function of Pill g036 Medication

In the g036 white oval pill (Lortab 7.5-325), Hydrocodone is a synthetic opioid with agonist characteristics. As an agonist, it releases the chemical to activate and bind with the mu-receptor in the central nervous system. All these mechanisms send signals to the body to respond to the pain.

Side Effects of Lortab 7.5-325 mg Drug

Hallucination, faintness, difficulty waking up, decreased appetite, nausea, stomach problems, light-headedness, lethargy, mental clouding, mood swings, urinary retention (not able to keep bladder empty), etc.

Note On g036 White Oval Pill:

Lortab 7.5-325 was discontinued based on contraindications due to the presence of the two components in this drug. It causes bronchial asthma, extreme respiratory depression, and intestinal obstruction in persons. Hence, this medication was discontinued in the U.S. However, its generic variants are approved by the U.S. FDA (Food and Drug Administration).